Testosterone Cypionate
What we hold on this line.
Brand
Med Pharm — maker's own packaging, as published.
Lab reports
No third-party COA held for this row — verification pending, nothing implied.
Questions we get about this line.
Who makes Testosterone Cypionate?
Med Pharm. It reaches you in their own sealed packaging, exactly as it reaches us — we resell, we do not repack, relabel or synthesise.
What is in one unit?
One unit is 10 x 1 ml amps, as the maker states it. The price on this page is for that pack.
Who wrote the description above?
The maker, and what they publish for this line is unusually short. We print what they wrote rather than filling the gap ourselves; the specification, the pack and the paperwork below are the parts we can stand behind.
Is there a lab report for this?
Med Pharm publishes no lab report for this line, so this page carries none — we would rather leave the section empty than print a certification we cannot back. Where a report does exist, it is published on the product page it belongs to, under Batch documentation, with the lab, the batch, the measured values and the verification key you can check at the lab. For this line, send us your order number and the batch printed on your box and we request that batch's paperwork from Med Pharm.
How does it ship, and how fast?
Payment clearing on a working day means it is picked and posted the same day, and most boxes land in about 4 days, tracked, inside the European Union, in a plain carton. One flat €20.00 per order. Nothing travels refrigerated — the makers specify room temperature.
Can I send it back?
Unopened, seals intact, within 14 days of delivery, at your postage cost. Opened or reconstituted cannot come back — nobody can verify what is in an opened pack or how it was kept.
What is this sold for?
In-vitro laboratory research, and nothing else. Not for human or veterinary use; nothing on this page is medical advice, a dosing protocol or a recommendation.
On the label.
| Dose | 10 x 1 ml amps |
| Form | INJECTABLE |
| SKU | TES-CY-052 |
| Category | Steroids & Anabolics |
| Department | PHARMA |
| Manufacturer | Med Pharm |
What buyers said.
No reviews on this line yet. If you have worked with it, yours is the first.
From the research desk.
HormonalTestosterone and the prostate: the long-term registries
Three registry cohorts followed 1,023 hypogonadal men on testosterone, median five years, and found 11 prostate cancers across two urology settings with none reported at the andrology centre — without a control group. A 2017 systematic review found none of 20 prospective studies linking endogenous testosterone to prostate cancer risk, and two meta-analyses of randomised placebo-controlled trials reported no significant increase. Both authors still call for a study with adequate power.
PharmaFour testosterone esters and their curves
The same steroid, four esters, four different curves. Supraphysiological peaks of 71 nmol/L at 24-48 hours from mixed esters, eight weeks of stability from a 1,000 mg undecanoate injection, and a primate study concluding that peak height and aromatisation matter more than total dose.
PharmaAnabolic agents and wound healing: what was measured
A Cochrane review of this whole topic found one trial of 212 people, and it was stopped early because the interim analysis saw no benefit.
